Consequences of Eccentric Cycling on Exercise-related Neuromuscular Responses and Biomarkers in Breast Cancer Patients
NCT ID: NCT05166148
Last Updated: 2022-05-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2021-11-22
2022-04-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Session (a): eccentric cycling
* Session (b): high intensity concentric cycling realized at the same mechanical power output than eccentric cycling
* Session (c): low intensity concentric cycling realized at the same metabolic demand than eccentric cycling The 3 sessions will be performed for each patient and order will be randomized.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adapted Physical Activity Effect and Fatigue in Patients With Breast Cancer
NCT01322412
All-extremity Exercise During Breast Cancer Chemotherapy
NCT04914663
Effect of Physical Exercise on Tumor Proliferation of Luminal B Breast Cancer Patients
NCT03860740
Exercise in Triple- Negative Breast Cancer
NCT06672120
Exercise Post-Diagnosis of Breast Cancer
NCT04013568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Visit 1: determination of maximal O2 consumption (VO2max) and first familiarization session to eccentric cycling Visits 2, 3 and 4: second, third and fourth eccentric cycling familiarization sessions Visits 5, 7 and 9: cycling sessions (a), (b) and (c) attributed in a random order Visits 6, 8 and 10: post-24h measurements after cycling sessions
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
eccentric cycling compared to concentric cycling
Every participant will perform the same protocol and will participated to the 3 experimental sessions (a, b and c) of the assigned intervention.
Session (a)
Eccentric cycling
Session (b)
High intensity concentric cycling realized at the same mechanical power output than eccentric cycling
Session (c)
Low intensity concentric cycling realized at the same metabolic demand than eccentric cycling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Session (a)
Eccentric cycling
Session (b)
High intensity concentric cycling realized at the same mechanical power output than eccentric cycling
Session (c)
Low intensity concentric cycling realized at the same metabolic demand than eccentric cycling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Woman under hormonotherapy, or menopausal woman, or woman in amenorrhea
Exclusion Criteria
* psychiatric, musculoskeletal or neurological disorders
* presenting at least one contraindication to the use of the transcranial magnetic stimulation
* presenting at least one contraindication to the realisation of the maximum effort test
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut de cancérologie Strasbourg Europe
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roland SCHOTT, MD
Role: PRINCIPAL_INVESTIGATOR
Institut de cancérologie Strasbourg Europe
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut de cancérologie Strasbourg Europe
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.